ITK inhibitor 2
≥98%
- Product Code: 125054
CAS:
1309784-09-5
| Molecular Weight: | 435.56 g./mol | Molecular Formula: | C₂₅H₃₃N₅O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
ITK inhibitor 2 is primarily utilized in research and development within the field of immunology and oncology. It is employed to study and modulate T-cell signaling pathways, particularly those involving the interleukin-2-inducible T-cell kinase (ITK). By inhibiting ITK, researchers can investigate its role in T-cell activation, proliferation, and function, which is crucial for understanding autoimmune diseases, allergic responses, and cancer immunotherapy. Additionally, this compound is used in preclinical studies to evaluate its potential as a therapeutic agent for targeting T-cell-mediated disorders and enhancing the efficacy of immune-based treatments. Its application extends to exploring mechanisms of immune regulation and developing novel strategies for managing conditions where T-cell activity is dysregulated.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | $405.04 |
+
-
|
ITK inhibitor 2
ITK inhibitor 2 is primarily utilized in research and development within the field of immunology and oncology. It is employed to study and modulate T-cell signaling pathways, particularly those involving the interleukin-2-inducible T-cell kinase (ITK). By inhibiting ITK, researchers can investigate its role in T-cell activation, proliferation, and function, which is crucial for understanding autoimmune diseases, allergic responses, and cancer immunotherapy. Additionally, this compound is used in preclinical studies to evaluate its potential as a therapeutic agent for targeting T-cell-mediated disorders and enhancing the efficacy of immune-based treatments. Its application extends to exploring mechanisms of immune regulation and developing novel strategies for managing conditions where T-cell activity is dysregulated.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :